Aon Rallies Into Q3 Print as Analysts Cut Targets

Aon plc reports third-quarter results on October 30 after spending much of 2026 under pressure from a controversial acquisition, then surging 7.3% over the past week to $315.72, far ahead of the 0.8% median gain for its closest insurance brokerage peers.

The week's move is striking given the analyst backdrop. Between early October and mid-October, firms across the Street trimmed their price targets in coordinated fashion: Morgan Stanley cut from $410 to $350, JPMorgan from $412 to $362, and Wells Fargo from $383 to $323, all while maintaining positive ratings. The pattern repeated across Mizuho, Barclays, Cantor Fitzgerald and Keefe, Bruyette & Woods. The consensus price target now stands at $353.58, implying around 12% upside from current levels, but that figure has been compressed substantially from where it was a month ago. The unanimous direction of the cuts, rather than any single note, is the clearest read on where the Street's caution lies.

That caution centres on the USI acquisition, which sits at the heart of both the bull and bear cases. Bears argue the deal was struck at 22x EBITDA, well above Aon's own trading multiple of roughly 11x EV/EBITDA, leaving the combined company carrying elevated leverage toward 4.5x and roughly $877 million of expected annual interest expense by 2027, alongside an estimated $550 million of integration costs and $400 million of retention costs, all of which arrive before meaningful synergy benefits flow through. Bulls take the other side: they point to 2026 EPS estimates of around $19.10 stepping to $21.70 and then $24.40 in subsequent years, a leverage reset path toward 3x within 24 months, and more than $1 billion of planned share repurchases in 2026. The NFP integration, which investors had feared, has proceeded more smoothly than expected, which gives the bull case some empirical footing heading into the print.

Options positioning has moved decisively toward the bullish camp alongside the share price recovery. The put/call ratio has dropped to 0.72, slightly below its 20-day average of 0.73 and well off the defensive levels above 0.90 that were common through September. That shift is consistent with call activity picking up as the stock recovered. Short interest, at 1.7% of the free float, remains low and has fallen 8% over the past week. Borrow availability is enormous, roughly 6,400% of outstanding short interest, meaning there is no scarcity of shares to borrow and no mechanical pressure building on the short side.

One institutional data point worth noting: JPMorgan Chase filed an amended Schedule 13G in October, lifting its disclosed stake from 5.6% to 6.7%, adding around 2 million shares at the group level. That sits alongside BlackRock at 7.4% and Vanguard at roughly 7%, a register dominated by large passive and active managers with no activist presence. Director Lester B. Knight made open-market purchases totalling approximately $4.6 million in early September at prices between $325 and $331, without a pre-arranged trading plan, a notable data point given where the stock was trading at the time.

Thursday's report will test whether Aon can demonstrate that the USI transaction's financial burden is tracking toward the synergy timeline management has outlined, or whether the Q3 numbers confirm the Street's nervousness about near-term earnings dilution.